rs199792389
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PP3_StrongBS2
The NM_000292.3(PHKA2):c.1493C>T(p.Pro498Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000247 in 1,190,422 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 93 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000292.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PHKA2 | NM_000292.3 | c.1493C>T | p.Pro498Leu | missense_variant | 15/33 | ENST00000379942.5 | NP_000283.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PHKA2 | ENST00000379942.5 | c.1493C>T | p.Pro498Leu | missense_variant | 15/33 | 1 | NM_000292.3 | ENSP00000369274 | P1 | |
PHKA2 | ENST00000464455.1 | n.62C>T | non_coding_transcript_exon_variant | 2/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000108 AC: 12AN: 111419Hom.: 0 Cov.: 22 AF XY: 0.000149 AC XY: 5AN XY: 33623
GnomAD3 exomes AF: 0.0000709 AC: 13AN: 183417Hom.: 0 AF XY: 0.0000442 AC XY: 3AN XY: 67855
GnomAD4 exome AF: 0.000261 AC: 282AN: 1079003Hom.: 0 Cov.: 27 AF XY: 0.000254 AC XY: 88AN XY: 346025
GnomAD4 genome AF: 0.000108 AC: 12AN: 111419Hom.: 0 Cov.: 22 AF XY: 0.000149 AC XY: 5AN XY: 33623
ClinVar
Submissions by phenotype
Glycogen storage disease IXa1 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 16, 2022 | ClinVar contains an entry for this variant (Variation ID: 526622). This missense change has been observed in individual(s) with glycogen storage disease (PMID: 17689125, 28283841, 34117828). This variant is present in population databases (rs199792389, gnomAD 0.02%), and has an allele count higher than expected for a pathogenic variant. This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 498 of the PHKA2 protein (p.Pro498Leu). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PHKA2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 28, 2022 | Variant summary: PHKA2 c.1493C>T (p.Pro498Leu) results in a non-conservative amino acid change located in the GH15-like domain (IPR011613) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 7.1e-05 in 183417 control chromosomes, including 3 hemizygotes. c.1493C>T has been reported in the literature in individuals affected with Glycogen Storage Diseases (e.g. Beauchamp_2007, Bali_2017, Benner_2021). The variant was also seen in three male hemizygous individuals from one family: two brothers affected with severe ketotic hypoglycemia as infants and one clinically unaffected uncle (Benner_2021). The variant was also seen in 4 female carriers, including the probands mother who had mild hypoglycemia and three unaffected female cousins born from the unaffected hemizygotic uncle. This pedigree does provide unequivocal evidence for or against causality. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three ClinVar submitters have assessed the variant since 2014: all have classified the variant as of uncertain significance. Based on the evidence outlined above, the variant was classified as VUS. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 28, 2022 | The c.1493C>T (p.P498L) alteration is located in exon 15 (coding exon 15) of the PHKA2 gene. This alteration results from a C to T substitution at nucleotide position 1493, causing the proline (P) at amino acid position 498 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
PHKA2-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 21, 2024 | The PHKA2 c.1493C>T variant is predicted to result in the amino acid substitution p.Pro498Leu. This variant was reported in a male with suspected glycogen storage disease type IX (GSD IX) (Beauchamp et al 2007. PubMed ID: 17689125). Additionally, it has been observed in two male siblings with symptomatic ketotic hypoglycemia (Benner et al. 2021. PubMed ID: 34117828). This variant is reported in 0.015% of alleles in individuals of African descent in gnomAD, including >90 hemizygotes in the larger gnomAD v4.1 dataset (https://gnomad.broadinstitute.org/variant/X-18925744-G-A?dataset=gnomad_r4). While we suspect this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Apr 29, 2020 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 17689125, 18950708) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at